Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 23476041)

1.

Vascular calcification--is aldosterone a culprit?

Lang F, Ritz E, Voelkl J, Alesutan I.

Nephrol Dial Transplant. 2013 May;28(5):1080-4. doi: 10.1093/ndt/gft041. Epub 2013 Mar 8. Review.

2.

Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice.

Voelkl J, Alesutan I, Leibrock CB, Quintanilla-Martinez L, Kuhn V, Feger M, Mia S, Ahmed MS, Rosenblatt KP, Kuro-O M, Lang F.

J Clin Invest. 2013 Feb;123(2):812-22. doi: 10.1172/JCI64093. Epub 2013 Jan 9.

3.

NH4Cl Treatment Prevents Tissue Calcification in Klotho Deficiency.

Leibrock CB, Alesutan I, Voelkl J, Pakladok T, Michael D, Schleicher E, Kamyabi-Moghaddam Z, Quintanilla-Martinez L, Kuro-O M, Lang F.

J Am Soc Nephrol. 2015 Feb 2. pii: JASN.2014030230. [Epub ahead of print]

PMID:
25644113
4.

Impact of aldosterone on osteoinductive signaling and vascular calcification.

Lang F, Ritz E, Alesutan I, Voelkl J.

Nephron Physiol. 2014;128(1-2):40-5. doi: 10.1159/000368268. Epub 2014 Nov 6.

5.

Stanniocalcin 2 is associated with ectopic calcification in α-klotho mutant mice and inhibits hyperphosphatemia-induced calcification in aortic vascular smooth muscle cells.

Takei Y, Yamamoto H, Sato T, Otani A, Kozai M, Masuda M, Taketani Y, Muto-Sato K, Lanske B, Takeda E.

Bone. 2012 Apr;50(4):998-1005. doi: 10.1016/j.bone.2012.01.006. Epub 2012 Jan 21.

PMID:
22285620
6.

25-Hydroxyvitamin D3 1-α-hydroxylase-dependent stimulation of renal klotho expression by spironolactone.

Alesutan I, Feger M, Pakladok T, Mia S, Ahmed MS, Voelkl J, Lang F.

Kidney Blood Press Res. 2013;37(4-5):475-87. doi: 10.1159/000355728. Epub 2013 Nov 7.

PMID:
24247665
7.

Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23.

Lim K, Lu TS, Molostvov G, Lee C, Lam FT, Zehnder D, Hsiao LL.

Circulation. 2012 May 8;125(18):2243-55. doi: 10.1161/CIRCULATIONAHA.111.053405. Epub 2012 Apr 5.

8.

Endogenous aldosterone is involved in vascular calcification in rat.

Wu SY, Yu YR, Cai Y, Jia LX, Wang X, Xiao CS, Tang CS, Qi YF.

Exp Biol Med (Maywood). 2012 Jan;237(1):31-7. doi: 10.1258/ebm.2011.011175. Epub 2011 Dec 20.

PMID:
22185918
9.

Early chronic kidney disease-mineral bone disorder stimulates vascular calcification.

Fang Y, Ginsberg C, Sugatani T, Monier-Faugere MC, Malluche H, Hruska KA.

Kidney Int. 2014 Jan;85(1):142-50. doi: 10.1038/ki.2013.271. Epub 2013 Jul 24.

10.

Growth-associated hyperphosphatemia in young recipients accelerates aortic allograft calcification in a rat model.

Yamauchi H, Motomura N, Chung UI, Sata M, Takai D, Saito A, Ono M, Takamoto S.

J Thorac Cardiovasc Surg. 2013 Feb;145(2):522-30. doi: 10.1016/j.jtcvs.2012.03.010. Epub 2012 Apr 17.

PMID:
22513315
11.

Mineralocorticoid receptor activation promotes vascular cell calcification.

Jaffe IZ, Tintut Y, Newfell BG, Demer LL, Mendelsohn ME.

Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):799-805. Epub 2007 Jan 18.

12.

Vascular calcification in chronic kidney disease.

Jono S, Shioi A, Ikari Y, Nishizawa Y.

J Bone Miner Metab. 2006;24(2):176-81. Review.

PMID:
16502129
13.

Connections between vascular calcification and progression of chronic kidney disease: therapeutic alternatives.

Hruska KA, Mathew S, Davies MR, Lund RJ.

Kidney Int Suppl. 2005 Dec;(99):S142-51.

14.

Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia.

Yamada S, Tokumoto M, Tatsumoto N, Taniguchi M, Noguchi H, Nakano T, Masutani K, Ooboshi H, Tsuruya K, Kitazono T.

Am J Physiol Renal Physiol. 2014 Jun 15;306(12):F1418-28. doi: 10.1152/ajprenal.00633.2013. Epub 2014 May 7.

PMID:
24808541
15.

Klotho deficiency causes vascular calcification in chronic kidney disease.

Hu MC, Shi M, Zhang J, Quiñones H, Griffith C, Kuro-o M, Moe OW.

J Am Soc Nephrol. 2011 Jan;22(1):124-36. doi: 10.1681/ASN.2009121311. Epub 2010 Nov 29.

16.

Vitamin D and vascular calcification in chronic kidney disease.

Rodriguez M, Martinez-Moreno JM, Rodríguez-Ortiz ME, Muñoz-Castañeda JR, Almaden Y.

Kidney Blood Press Res. 2011;34(4):261-8. doi: 10.1159/000326903. Epub 2011 Jun 21. Review.

PMID:
21691129
17.

p53 negatively regulates the osteogenic differentiation of vascular smooth muscle cells in mice with chronic kidney disease.

Li KL, Chen J, Li ZH, Zhao L, He YN.

Cardiovasc J Afr. 2012 Jul 12;23(6):e1-9. doi: 10.5830/CVJA-2011-069.

18.

Fetuin-A protects against atherosclerotic calcification in CKD.

Westenfeld R, Schäfer C, Krüger T, Haarmann C, Schurgers LJ, Reutelingsperger C, Ivanovski O, Drueke T, Massy ZA, Ketteler M, Floege J, Jahnen-Dechent W.

J Am Soc Nephrol. 2009 Jun;20(6):1264-74. doi: 10.1681/ASN.2008060572. Epub 2009 Apr 23.

19.

Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease.

Mathew S, Davies M, Lund R, Saab G, Hruska KA.

Eur J Clin Invest. 2006 Aug;36 Suppl 2:43-50.

PMID:
16884397
20.

Phosphate is a vascular toxin.

Shroff R.

Pediatr Nephrol. 2013 Apr;28(4):583-93. doi: 10.1007/s00467-012-2347-x. Epub 2012 Nov 17. Review.

PMID:
23161206
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk